Alle Storys
Folgen
Keine Story von Marseille-Kliniken AG mehr verpassen.

Marseille-Kliniken AG

EANS-News: Marseille-Kliniken AG continues increase in earnings in first half of 2011/2012

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
6-month report

Subtitle: - EBIT expanded by over 50 percent to EUR 5.0 million
- Revenue increased to EUR 96.8 million
- Occupancy rate with 88.6 percent above market average
- Forecast of approximately EUR 10.0 million EBIT for whole fiscal year
confirmed

Hamburg (euro adhoc) - 13 February 2012 - According to today´s reported results
for the first half of fiscal year 2011/2012 (July 1 to December 31, 2011)
Marseille-Kliniken AG increased its profitability significantly. The occupancy
rate increased to 88.6 percent (Q2 2010/2011: 86.9 percent). Therefore revenues
expanded to EUR 96.8 million (previous year: EUR 95.2 million) and EBIT
increased from EUR 3.2 million to EUR 5.0 million. "With these results we
continue the improvement of our profitability. The Company is on track for
reaching our guidance for full fiscal year 2011/2012." says Michael Thanheiser,
chairman of Marseille-Kliniken AG.

Since fiscal year 2010/2011 Marseille-Kliniken AG fosters growth by a strategy
mix which includes a focus on care for elderly, quality leadership and a
decentralised management structure. Moreover an initiative carried out to
optimise costs also played a role in supporting the company's economic recovery.

This trend continued in the results published today. With an increase of 2.0
percent to 88.6 percent, the occupancy rate exceeded the market average (88
percent). 

Coincidently with the expansion of revenues, total expenses declined from EUR
96.0 million in previous year to EUR 94.2 million. Due to this EBITDAR increased
by 1.5 percent to EUR 26.9 million (previous year: EUR 26.5 million) and EBITDA
rose by 15.3 percent to EUR 8.3 million (previous year: EUR 7.2 million). Total
group earnings increased to EUR 4.1 million (previous year: EUR 0.3 million).
This results in EUR 0.27 earnings per share (previous year: EUR 0.02). Overall
Marseille-Kliniken AG operates a total of 60 care facilities across Germany,
with a sales capacity of 7,953 beds on 31 December 2011.

Against the backdrop of the half yearly results, Marseille-Kliniken AG confirms
its forecast for
full 2011/2012 financial year, which calls for a slight revenue increase and
Group EBIT of
EUR 10.0 million, well above the previous year's level. The corresponding report
for the first half of fiscal year 2011/2012 is available to the public today on
the company's website at www.marseille-kliniken.com.

---- End of press release ----

About Marseille-Kliniken AG:

Marseille-Kliniken AG with its 57 residential care facilities, three residential
units for assisted living and about 4,700 employees is a market leading listed
company on health care in Germany. The business model is significantly
influenced by the demographic development. Therefore Marseille-Kliniken AG has a
secured future. Short-term economic fluctuations on the other hand exert only a
minor influence. As a consistently modern company, the firm is in a good
position within a competitive environment primarily determined by regionally
active charities.


Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:         info@marseille-kliniken.de
WWW:         http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English

Original-Content von: Marseille-Kliniken AG, übermittelt durch news aktuell

Weitere Storys: Marseille-Kliniken AG
Weitere Storys: Marseille-Kliniken AG